Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 64

Results For "University"

750 News Found

New CellScape system for high-plex and high-throughput targeted spatial proteomics
Medical Device | March 04, 2022

New CellScape system for high-plex and high-throughput targeted spatial proteomics

ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease


Govt announces over Rs 100 crore investment for Ayush sector in Nagaland
Public Health | March 04, 2022

Govt announces over Rs 100 crore investment for Ayush sector in Nagaland

Ten new Ayush hospitals and one Ayurvedic college will be set up in Nagaland and Mizoram


Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
Biotech | March 03, 2022

Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases

Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy


Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology
Biotech | March 03, 2022

Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology

Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal


Trivitron Healthcare acquires U.S. based The Kennedy Company
Clinical Trials | March 02, 2022

Trivitron Healthcare acquires U.S. based The Kennedy Company

This has further strengthened its manufacturing presence in the United States of America


China’s NMPA accepts supplemental NDA for Carteyva
Drug Approval | February 28, 2022

China’s NMPA accepts supplemental NDA for Carteyva

The sNDA was supported by the clinical results from cohort B of a single-arm, multi-center, pivotal study (RELIANCE study) on Carteyva in adult patients with relapsed or refractory B cell non-hodgkin lymphoma in China


Jeffrey DeAlmeida appointed Senior VP of BASF pharma solutions
People | February 28, 2022

Jeffrey DeAlmeida appointed Senior VP of BASF pharma solutions

In this role, Jeffrey DeAlmeida takes responsibility for BASF’s global pharmaceutical solutions portfolio and the Nutrition & Health business in North and South America


LivaNova announces first patient implanted in OSPREY clinical study
Medical Device | February 27, 2022

LivaNova announces first patient implanted in OSPREY clinical study

Study to evaluate effectiveness of hypoglossal nerve stimulation


Daewoong  completes combination therapy of antidiabetic drug Enavogliflozin
News | February 27, 2022

Daewoong completes combination therapy of antidiabetic drug Enavogliflozin

Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy


Cantex and Harvard's Wyss Institute to expand development of Azeliragon
News | February 27, 2022

Cantex and Harvard's Wyss Institute to expand development of Azeliragon

Cantex also plans to initiate Phase 2 clinical trials exploring the therapeutic effect of azeliragon in pancreatic and breast cancers.